Participation in studies of other experimental drugs or devices within 30 days prior to enrollment in this study

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Hhart Disease
  • Age: Between 18 - 110 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Subjects who are able to provide informed consent.
    2. Subjects with presence of a structural heart defect (e.g., Mitral Valve regurgitation, Atrial Fibrillation, Patent foramen ovale) requiring a Transcatheter therapeutic procedure such as Left Atrium Appendage Closure, Transcatheter Aortic Valve Replacement or Transcatheter Mitral Valve Repair
    3. Subjects who are at least 18 years old

You may not be eligible for this study if the following are true:

    1. Subjects who do not have a structural heart defect requiring a Transcatheter therapeutic procedure such as Left Atrium Appendage Closure, Transcatheter Aortic Valve Replacement or Transcatheter Mitral Valve Repair
    2. Subjects with bleeding diathesis.
    3. Subjects with vascular abnormality rendering right heart catheterization from a right or left femoral venous approach impossible.
    4. Subject with right heart intracardiac thrombus.
    5. Subjects with class IV angina or heart failure.
    6. Subjects unable or unwilling to provide informed consent
    7. Female subjects of child-bearing potential in the absence of surgical sterilization or negative pregnancy test within 48 hours prior to the procedure
    8. Subjects with sepsis or other active infection
    9. Subjects with immunodeficiency disorder or of an immune-compromised state
    10. Subjects participating in studies of other experimental drugs or devices within 30 days prior to enrollment in this study



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.